When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Urethritis

Última revisão das evidências: 17 Sep 2026
Última atualização do tópico: 25 Sep 2026
06 May 2026

FDA approves new oral antibiotics effective against resistant strains of gonorrhea

Two new oral antibiotics, zoliflodacin and gepotidacin, have been approved by the Food and Drug Administration (FDA) for treating patients with uncomplicated urogenital gonorrhea in patients age 12 years and older. The gepotidacin approval is restricted to patients with few or no other treatment choices because of limited safety data.

Zoliflodacin and gepotidacin have novel mechanisms of action, which means they are effective against strains of Neisseria gonorrhoeae that are resistant to currently recommended antibiotics. Gepotidacin and zoliflodacin act by inhibiting bacterial DNA replication.

The new antibiotics provide oral treatment options and alternative treatments for resistant strains of N gonorrhoeae.

Ver Tratamento: novidades

Fonte original da atualização

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • urethral discharge
  • urethral erythema, irritation and/or itching
  • dysuria
  • vaginal discharge and/or bleeding
Detalhes completos

Outros fatores diagnósticos

  • orchialgia
  • testicular or epididymal pain
  • pelvic pain (women)
Detalhes completos

Fatores de risco

  • age 15-24 years
  • men who have sex with men
  • new or multiple sex partners
  • prior or current STI
  • unprotected sex
  • circumcision
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • Gram stain of urethral discharge
  • urinalysis
  • nucleic acid amplification testing
  • HIV test
  • syphilis test
Detalhes completos

Investigações a serem consideradas

  • urine flow cytometry
  • urine culture
  • nucleic acid amplification testing for Trichomonas vaginalis
  • wet mount or culture for Trichomonas vaginalis
  • extragenital nucleic acid amplification testing
  • nucleic acid amplification testing for other organisms
  • potassium hydroxide prep of urethral discharge
  • antibiotic susceptibility testing
Detalhes completos

Algoritmo de tratamento

Inicial

presumptive diagnosis: nonpregnant

presumptive diagnosis: pregnant

AGUDA

confirmed urethritis: nonpregnant

confirmed urethritis: pregnant

CONTÍNUA

recurrent or resistant urethritis

Colaboradores

Autores

Lisa Istorico Sanders, MD

Associate Professor

Pediatric Infectious Diseases

University of South Florida Morsani College of Medicine

Executive Director

Ybor Youth Clinic

Tampa, FL

Declarações

LIS is part of the Adolescent Medicine Trials Network grant at the University of South Florida Department of Pediatrics. LIS is involved in a study (ATN 173) of doxycycline prophylaxis for sexually transmitted infections (STIs) in those identified as female at birth at risk for acquiring STIs.

Agradecimentos

Dr Lisa Istorico Sanders would like to gratefully acknowledge Dr Sheldon Morris and Dr Christina Bailey previous contributors to this topic.

Declarações

CB declares that she has no competing interests.

Revisores

Vani Dandolu, MD, MPH

Associate Professor

Ob/Gyn and Urology

Director

Division of Urogynecology

Associate Residency Program Director

Temple University Hospital

Philadelphia, PA

Declarações

VD declares that he has no competing interests.

Khalil Ghanem, MD, PhD

Assistant Professor of Medicine

Associate Fellowship Program Director

Division of Infectious Diseases

Johns Hopkins University School of Medicine

Baltimore, MD

Declarações

KG declares that he has no competing interests.

Christopher Fairley, PhD

Professor of Sexual Health

University of Melbourne

Director

Melbourne Sexual Health Centre

Carlton

Victoria

Australia

Declarações

CF is an author of a number of references cited in this topic. CF has received program grants of 6 figures US$.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo  Resumo

Crofts M, Blee K, Evans C, et al. British Association of Sexual Health and HIV national guideline on the management of non-gonococcal urethritis (NGU), 2026. Int J STD AIDS. 2026 Jun;37(7):690-703.Texto completo  Resumo

European Association of Urology. Guidelines on urological infections. Mar 2026 [internet publication].Texto completo

Soni S, Fifer H, Al-Shakarchi Y, et al. British Association of Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium, 2025. Int J STD AIDS. 2026 May;37(6):576-88.Texto completo  Resumo

Horner PJ, Blee K, Falk L, et al; International Union against Sexually Transmitted Infections. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016 Oct;27(11):928-37.Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Urethritis images
  • Diagnósticos diferenciais

    • Urinary tract infection
    • Candida balanitis or vaginitis
    • Noninfectious urethritis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines on urological infections
    • Canadian guidelines on sexually transmitted and blood-borne infections
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Chlamydia

    Gonorrhea

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal